Gorlick, Richard

Selected publications

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee. Pediatric Blood and Cancer. 2016 Academic Article GET IT
Times cited: 13
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. The Lancet Oncology. 2016 Academic Article GET IT
Times cited: 98
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. Journal of the National Cancer Institute. 2016 Academic Article GET IT
Times cited: 70
Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma. Clinical Orthopaedics and Related Research. 2016 Academic Article GET IT
Times cited: 11
Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial. Journal of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 127
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Human Molecular Genetics. 2014 Academic Article GET IT
Times cited: 61
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood and Cancer. 2014 Academic Article GET IT
Times cited: 10
Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma. Frontiers in Oncology. 2013 Academic Article GET IT
Times cited: 28
Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatric Blood and Cancer. 2013 Academic Article GET IT
Times cited: 30
Outcome for adolescent and young adult patients with osteosarcoma: A report from the Children's Oncology Group. Cancer. 2012 Academic Article GET IT
Times cited: 91
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: A report from the children's oncology group. Journal of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 119
Addition of pamidronate to chemotherapy for the treatment of osteosarcoma. Cancer. 2011 Academic Article GET IT
Times cited: 84
Impairment of methotrexate transport is common in osteosarcoma tumor samples. Sarcoma. 2011 Academic Article GET IT
Times cited: 18
Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance. Molecular Cancer Therapeutics. 2009 Academic Article GET IT
Times cited: 34
Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors. Cancer. 2009 Academic Article GET IT
Times cited: 13
Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. Journal of Orthopaedic Research. 2008 Academic Article GET IT
Times cited: 30
Hypoxia markers in human osteosarcoma: An exploratory study. Clinical Orthopaedics and Related Research. 2008 Academic Article GET IT
Times cited: 54
Polymorphisms and methylation of the reduced folate carrier in osteosarcoma. Clinical Orthopaedics and Related Research. 2008 Academic Article GET IT
Times cited: 16
The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue. Pediatric Blood and Cancer. 2008 Academic Article GET IT
Times cited: 32
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer. 2008 Academic Article GET IT
Times cited: 86
Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier. BMC Cancer. 2008 Academic Article GET IT
Times cited: 24
In reply [10]. Journal of Clinical Oncology. 2007 Information Resource GET IT
Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients. Pediatric Blood and Cancer. 2007 Academic Article GET IT
Times cited: 16
Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. International Journal of Cancer. 2007 Academic Article GET IT
Times cited: 40
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. Journal of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 78
The folate receptor α is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Clinical Cancer Research. 2007 Academic Article GET IT
Times cited: 38
Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Cancer. 2006 Academic Article GET IT
Times cited: 38
FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. Journal of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 77
Cell proliferation of cultured human cancer cells are affected by the elevated tumor pressures that exist in vivo. Annals of Biomedical Engineering. 2005 Academic Article GET IT
Times cited: 34
Methotrexate levels and outcome in osteosarcoma. Pediatric Blood and Cancer. 2005 Academic Article GET IT
Times cited: 23
Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clinical Cancer Research. 2005 Academic Article GET IT
Times cited: 121
Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clinical Cancer Research. 2005 Academic Article GET IT
Times cited: 52
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Research. 2005 Academic Article GET IT
Times cited: 155
An ¹⁹F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: Proof of principle. Clinical Cancer Research. 2005 Academic Article GET IT
Times cited: 4
Malignant ectomesenchymoma in the wrist of a child: Case report and review of the literature. International Journal of Surgical Pathology. 2005 Review GET IT
Times cited: 10
Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-β-Catenin Pathway. Cancer Research. 2004 Academic Article GET IT
Times cited: 228
Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer Biology and Therapy. 2004 Academic Article GET IT
Times cited: 40
Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. International Journal of Cancer. 2004 Academic Article GET IT
Times cited: 129
Frequent Amplification and Rearrangement of Chromosomal Bands 6p12-p21 and 17p11.2 in Osteosarcoma. Genes Chromosomes and Cancer. 2004 Academic Article GET IT
Times cited: 112
The Patterns of Relapse in Osteosarcoma: The Memorial Sloan-Kettering Experience. Pediatric Blood and Cancer. 2004 Academic Article GET IT
Times cited: 46
Identification of Prognostic Markers in Bone Sarcomas Using Proton-Decoupled Phosphorus Magnetic Resonance Spectroscopy. Cancer Research. 2003 Academic Article GET IT
Times cited: 10
Biology of Childhood Osteogenic Sarcoma and Potential Targets for Therapeutic Development: Meeting Summary. Clinical Cancer Research. 2003 Review GET IT
Times cited: 140
Osteosarcoma Necrosis Following Chemotherapy: Innate Biology Versus Treatment-Specific. Journal of Pediatric Hematology/Oncology. 2003 Comment GET IT
Times cited: 29
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. Journal of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 126
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: A Children's Cancer Group study. Journal of Pediatric Hematology/Oncology. 2003 Academic Article GET IT
Times cited: 33
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma. Cancer. 2003 Academic Article GET IT
Times cited: 75
mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma. Molecular Cancer Therapeutics. 2003 Academic Article GET IT
Times cited: 46
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Research. 2003 Academic Article GET IT
Times cited: 144
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Human Molecular Genetics. 2003 Academic Article GET IT
Times cited: 116
Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clinical Cancer Research. 2003 Academic Article GET IT
Times cited: 46
Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. Journal of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 29
Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clinical Cancer Research. 2002 Academic Article GET IT
Times cited: 63
Irinotecan for pediatric solid tumors: The memorial Sloan-Kettering experience. Journal of Pediatric Hematology/Oncology. 2002 Academic Article GET IT
Times cited: 62
Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma. Clinical Orthopaedics and Related Research. 2001 Academic Article GET IT
Times cited: 46
Lack of correlation of functional scintigraphy with ^99mtechnetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma. Clinical Cancer Research. 2001 Academic Article GET IT
Times cited: 21
Numb chin syndrome in Ewing sarcoma. Journal of Pediatric Hematology/Oncology. 2000 Academic Article GET IT
Times cited: 6
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Research. 2000 Academic Article GET IT
Times cited: 82
Expression of bone morphogenetic proteins and receptors in sarcomas. Clinical Orthopaedics and Related Research. 1999 Academic Article GET IT
Times cited: 69
Mechanisms of methotrexate resistance in osteosarcoma. Clinical Cancer Research. 1999 Academic Article GET IT
Times cited: 126
Ewing's sarcoma in a patient with congenital optic atrophy. Journal of Pediatric Hematology/Oncology. 1998 Academic Article GET IT
Times cited: 2
Multicentric osteosarcoma, Rothmund-Thomson syndrome, and secondary nasopharyngeal non-Hodgkin's lymphoma: A case report and review of the literature. Journal of Pediatric Hematology/Oncology. 1998 Academic Article GET IT
Times cited: 27
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. Journal of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 97
γ-glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. Oncology Research. 1997 Academic Article GET IT
Times cited: 53

VIVO Weill Cornell Medical College

Gorlick, Richard External Author

Publications

Selected publications